Press Releases Bybit Increases Collateral Ratios Across UTA Loans, Expanding Borrowing Capacity for Traders August 6, 2026
Press Releases Disrupting Startup Failure Curve: Why Money and Skills Alone Are Not Enough August 6, 2026
Press Releases Silver Point Leads Financing of Acquisition of Central Wire Industries by Altair Industries August 6, 2026
Press Releases - Travel Sabre’s second quarter 2026 earnings materials available on its Investor Relations website August 6, 2026
Press Releases - Lifestyle NetEase Cloud Music Inc. to Report First Half 2026 Financial Results on August 20, 2026 August 6, 2026
Press Releases Silver Arch Capital Partners Provides $5,660,000 Loan for Mixed-Use Multifamily Development in Huntington Station, NY August 6, 2026
Press Releases IQST – IQSTEL Expects to Surpass an $8 Million Adjusted EBITDA Run Rate This Quarter as It Leverages Its Global Platform to Accelerate Growth August 6, 2026
Press Releases - Travel SUNSTONE HOTEL INVESTORS REPORTS RESULTS FOR SECOND QUARTER 2026 August 6, 2026
FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis 3 months ago